These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3320851)

  • 41. A controlled clinical trial in advanced ovarian cancer.
    Adams M; Johansen KA; James KW; Rocker I
    Clin Radiol; 1982 Mar; 33(2):161-3. PubMed ID: 7039940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study.
    Bolis G; Bortolozzi G; Carinelli G; D'Incalci M; Gramellini F; Morasca L; Mangioni C
    Cancer Chemother Pharmacol; 1980; 4(2):129-32. PubMed ID: 7389058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Present optimal therapy in ovarian cancer.
    Abrams J
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):9-12. PubMed ID: 3082643
    [No Abstract]   [Full Text] [Related]  

  • 44. Peptichemio versus melphalan (L-PAM) in advanced breast cancer.
    Buzdar AU; Legha SS; Blumenschein GR; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Fraschini G; Bodey GP
    Cancer; 1982 May; 49(9):1767-70. PubMed ID: 7042074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triple drug chemotherapy for advanced ovarian carcinoma: comparative study of two regimens.
    Aroney RS; Levi JA; Dalley DN
    Med J Aust; 1981 Jun; 1(12):633-5. PubMed ID: 7019638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CA 125 regression: a model for epithelial ovarian cancer response.
    Buller RE; Berman ML; Bloss JD; Manetta A; DiSaia PJ
    Am J Obstet Gynecol; 1991 Aug; 165(2):360-7. PubMed ID: 1872339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.
    Edmonson JH; Fleming TR; Decker DG; Jorgensen EO; Malkasian GD; Jefferies JA; Kvols LK; Webb MJ
    Recent Results Cancer Res; 1978; 68():157-9. PubMed ID: 752853
    [No Abstract]   [Full Text] [Related]  

  • 48. Adriamycin in ovarian cancer patients resistant to cyclophosphamide.
    Bolis G; D'Incalci M; Gramellini F; Mangioni C
    Eur J Cancer (1965); 1978 Dec; 14(12):1401-2. PubMed ID: 738344
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of clinical trials in gynecologic cancer--timing and interpretation.
    Blessing JA; Anderson B
    Gynecol Oncol; 1986 Mar; 23(3):275-83. PubMed ID: 3514389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
    Krommer K; Keller G; Csaba I; Garadnay B; Göcze P
    Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of intervention surgery in stage III-IV epithelial ovarian carcinoma.
    Hoogland H; Blijham G; Bron H; Eekhout A; van Geuns H; Haest J; Huiskes H; Kornman J; de Koning Gans H; Lalisang F
    Prog Clin Biol Res; 1985; 201():213-5. PubMed ID: 3841592
    [No Abstract]   [Full Text] [Related]  

  • 52. High-dose intensity regimens with epirubicin in ovarian cancer.
    Vermorken JB
    Pathol Biol (Paris); 1992 Nov; 39(9):833. PubMed ID: 1538894
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University].
    Krommer K
    Orv Hetil; 1992 May; 133(19):1151-8. PubMed ID: 1584596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer].
    Hernádi Z; Juhász B; Póka R; Mahunka I; Lampé L
    Orv Hetil; 1987 Nov; 128(47):2457-61. PubMed ID: 3320851
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.